AI Silk Corporation announced that it has received ¥320 million in funding from Global Brain Co., Ltd., EPSON X Investment Corporation, Fukuda Denshi Co., Ltd., Mizuho Capital Co., Ltd., Tohoku University Venture Partners Co.,Ltd.
May 14, 2023
Share
AI Silk Corporation announced that it has raised ¥?320 million in funding on May 15, 2023. The transaction included participation from new investors EP-GB Investment Limited Partnership, a fund managed by Global Brain Co., Ltd. and EPSON X Investment Corporation, Fukuda Denshi Co., Ltd., Mizuho Seicho Shien Fund 4, a fund managed by Mizuho Capital Co., Ltd., THVP-No. 1 Limited Partnership, a fund managed by Tohoku University Venture Partners Co.,Ltd.
FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.
AI Silk Corporation announced that it has received ¥320 million in funding from Global Brain Co., Ltd., EPSON X Investment Corporation, Fukuda Denshi Co., Ltd., Mizuho Capital Co., Ltd., Tohoku University Venture Partners Co.,Ltd.